In vivo therapeutic effects of affinity-improved-TCR engineered T-cells on HBV-related hepatocellular carcinoma
Qi Liu(Guangzhou Institutes of Biomedicine and Health), Yuefei Ren(University of Science and Technology of China), Peipei Zhou(John Brown University), Yaju Liu(University of Science and Technology of China), Wenxuan Cai(University of Wisconsin–Madison), Ye Tian(Northwest University), Yi Li(Guangzhou Institutes of Biomedicine and Health), Wei Zhang(State Forestry and Grassland Administration), Yajing Zhang(Guangzhou Institutes of Biomedicine and Health), Zhaoduan Liang(Anhui University), Yifeng Bao(Fudan University), Yanyan Li(Guangzhou Institutes of Biomedicine and Health)
Cited by 42
Related Papers
The landscape of aging
|Science China Life Sciences|2022|404
Caffeine
|Unknown|2016|300
Caffeine: Toward Uniformed Representation and Acceleration for Deep Convolutional Neural Networks
|IEEE Transactions on Computer-Aided Design of Integrated Circuits and Systems|2018|268
mTOR signaling at the crossroads of environmental signals and T‐cell fate decisions
|Immunological Reviews|2020|188